News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Cybin
Recent news which mentions Cybin
Cybin: Positive Data Announced From Innovative Drug Trial
March 02, 2023
Tags
Market News
General
Benzinga
From
Benzinga
Cybin: Psychedelic Based BioPharma Company To Announce Much Anticipated Updates For Its Ongoing Clinical Trials
February 27, 2023
Tags
Benzinga
General
Interview
From
Benzinga
Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment
February 01, 2023
Tickers
CYBN
DMT
Tags
CYB004
CYBN
Psychedelics
From
Benzinga
Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family
September 27, 2022
Tickers
CYBN
MSSTF
Tags
Doug Drysdale
Penny Stocks
Cannabis
From
Benzinga
BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression
August 17, 2022
Tickers
CYBN
DEA
MDD
Tags
Biotech
Doug Drysdale
Penny Stocks
From
Benzinga
This Psychedelics Company Is Setting Up An Equity Program For Up To $35M In Shares
August 09, 2022
Tickers
CYBN
SEC
Tags
Cantor Fitzgerald
Offerings
Psychedelics
From
Benzinga
How Does Ketamine Affect The Brain Over Time?
June 25, 2022
Tags
Kernel
Markets
Ketamine
From
Benzinga
Cybin Presents "Why Cybin Is Investing So Heavily On Developing Novel Psychedelic Molecules" At The Psychedelic Capital Conference
April 25, 2022
Tickers
CYBN
Tags
Markets
Partner Content
Penny Stocks
From
Benzinga
Cybin's Major Depressive Disorder Treatment Trials Continue With Clinilabs Drug Development Corp
April 22, 2022
Tickers
CYBN
Tags
Market News
Cybin
News
From
Benzinga
Cybin's CYB0004 Shows Positive Preclinical Results Over Traditional Psychedelics
April 13, 2022
Tickers
CYBN
Tags
Benzinga
Cannabis
Markets
From
Benzinga
WIPO Publishes Cybin's Patent Application For Inhaled Psychedelics Therapies
April 08, 2022
Tickers
CYBN
Tags
Psychedelics
Market News
World Intellectual Property Organization
From
Benzinga
A Builder From The Ground Up, Doug Drysdale, CEO of Cybin: Meet Our Speakers
April 06, 2022
Tickers
AGN
CYBN
PTX
Tags
Cannabis
Benzinga
AGN
From
Benzinga
Cybin Begins Study Using Kernel Flow Headsets To Measure Ketamine's Effects On The Brain
March 31, 2022
Tickers
CYBN
Tags
CYBN
Psychedelics
Kernel
From
Benzinga
Cybin Completes In Vivo Preclinical Studies For Major Depressive Disorder
March 29, 2022
Tickers
CYBN
Tags
Market News
Psychedelics
CYBN
From
Benzinga
Five Companies Developing Second Generation Psychedelics For Mental Health
March 24, 2022
Tickers
CYBN
ENVB
FTRP
MNMD
Tags
Markets
Field Trip
MNMD
From
Benzinga
Cybin Reports Q2 Financial Results And Latest News, Including FDA & DEA Research Approvals
November 15, 2021
Tickers
CYBN
Tags
Market News
CYBN
News
From
Benzinga
Cybin Announces Positive Data Showing Effectiveness of Psilocybin To Treat Depression
November 08, 2021
Tickers
CYBN
Tags
Penny Stocks
Biotech
Doug Drysdale
From
Benzinga
Cybin: FDA Authorizes Feasibility Study To Measure Ketamine's Effect On Cerebral Cortex
October 27, 2021
Tickers
CYBN
Tags
Penny Stocks
Biotech
Benzinga
From
Benzinga
Cybin Inc. (NEO: CYBN) (NYSE: CYBN) Files Two International Patent Applications In Support Of The Company's Research Phase Programs
August 19, 2021
Tickers
CYBN
Tags
research
Cybin
News
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.